Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
[PMID: 20445064] PubMed record related to this compound for laboratory literature review
In September 2024, after patient enrollment was complete, the company announced the trial failed to meet its primary cognitive efficacy endpoints
GHK further inhibited TGF-1, p-Smad2, p-Smad3, and IGF-1 expression, indicating its potential as a subject of further research in pulmonary fibrosis by targeting the TGF-1/Smad 2/3 and IGF-1 pathways
Final Thoughts MIC B12 injections offer a potential boost to metabolism and energy levels, combining key nutrients to support overall health
Standard cycles run 8-12 weeks of active use followed by 3-6 weeks off
US$ 22.42
US$ 20.94
US$ 20.26
